ABERDEEN JAPAN EQUITY FUND INC PHILADELPHIA, Aug. 21, 2015 /PRNewswire/ -- Aberdeen Japan Equity Fund, Inc. (the "Fund") (NYSE: JEQ), a closed-end equity fund, announced today its performance data and portfolio composition as of July 31, 2015.
http://photos.prnewswire.com/prnvar/20121106/NE07292LOGO
The Fund's total returns for various periods through July 31, 2015 are provided below. (All figures are based on distributions reinvested at the dividend reinvestment price and are stated net-of-fees):
Cumulative as of
07/31/15 Annualized as of 07/31/15
-------- -------------------------
1 Month 3 Month YTD 1 Year 3 Years 5 Years 10 Years Since Inception
------- ------- --- ------ ------- ------- -------- ---------------
NAV 0.4 -0.1 15.4 12.6 18.2 9.9 4.3 1.7
--- --- ---- ---- ---- ---- --- --- ---
Market Price -3.5 -2.3 17.7 10.6 18.2 9.9 3.5 1.1
------------ ---- ---- ---- ---- ---- --- --- ---
TOPIX 0.5 0.8 15.2 8.8 14.7 8.7 4.1 2.5
----- --- --- ---- --- ---- --- --- ---
On July 31, 2015, the Fund's net assets amounted to US$123.9 million and the Fund's NAV per share was $9.07.
As of July 31, 2015, the portfolio was invested as follows:
Portfolio Composition Percent of
Net Assets
--- ----------
Consumer Staples 21.2
---------------- ----
Industrials 18.0
----------- ----
Consumer Discretionary 14.9
---------------------- ----
Financials 13.0
---------- ----
Health Care 10.1
----------- ----
Materials 9.5
--------- ---
Information Technology 8.9
---------------------- ---
Telecommunications 3.7
------------------ ---
Cash 0.6
---- ---
The Fund's ten largest equity holdings as of July 31, 2015, representing 41.2% of net assets, were:
Stock Percent of
Net Assets
--- ----------
Japan Tobacco 5.7
------------- ---
Shin-Etsu Chemical 5.2
------------------ ---
Seven & I Holdings 4.3
------------------ ---
Keyence Corp. 4.2
------------- ---
East Japan Railway 3.8
------------------ ---
Amada Holdings 3.8
-------------- ---
KDDI Corp. 3.7
---------- ---
Toyota Motor Corp. 3.7
------------------ ---
Nabtesco Corp. 3.4
-------------- ---
Chugai Pharmaceutical 3.3
--------------------- ---
Important Information
Aberdeen Asset Management Inc. has prepared this report based on information sources believed to be accurate and reliable. All reasonable care has been taken to ensure accuracy. However, the figures are unaudited and neither the Fund, Aberdeen Asset Management Inc. (the current Administrator), Daiwa Securities Trust Company (the former Administrator), Aberdeen Asset Management Asia Limited (the Investment Manager), nor any other person guarantees their accuracy. Investors should seek their own professional advice and should consider the investment objectives, risks, charges and expenses before acting on this information. Aberdeen is a U.S. registered service mark of Aberdeen Asset Management PLC.
Closed-end funds are traded on the secondary market through one of the stock exchanges. The Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the Fund. There is no assurance that the Fund will achieve its investment objective.
Total return figures with distributions reinvested at the dividend reinvestment price are stated net-of-fees and represents past performance. Past performance is not indicative of future results, current performance may be higher or lower. Holdings are subject to change and are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities shown. Inception date July 24, 1992.
If you wish to receive this information electronically, please contact: InvestorRelations@aberdeen-asset.com
Logo - http://photos.prnewswire.com/prnh/20121106/NE07292LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aberdeen-japan-equity-fund-inc-announces-performance-data-and-portfolio-composition-300131685.html
SOURCE Aberdeen Japan Equity Fund, Inc.
